34612-38-9O=C[C@H](O)[C@@H](O)[C@H](O[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)COUYQJCPNSAVWAFU-KVXMBEGHSA-NMaltotetraose is a maltotetraose tetrasaccharide in which the glucose residue at the reducing end is in the aldehydo open-chain form. It has a role as an antibacterial agent and an Escherichia coli metabolite.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 100% (104 of 104) of all reports.
Not Classified
Aggregated GHS information provided per 104 reports by companies from 1 notifications to the ECHA C&L Inventory.
DescriptionMaltotetraose is a tetrasaccharide that is composed of glucose molecules linked by α-1,4 glycosidic bonds and has been found in B. stearothermophilus. It increases the α-amylase synthesis rate in B. stearothermophilus 3-fold greater than sucrose or glucose when used at a concentration of 0.1 mM. Maltotetraose (750 μg/ml) inhibits the growth of E. carotovora in a cylinder-agar plate assay but does not affect the growth of several other microorganisms. It also inhibits TNF-α-induced expression of intercellular adhesion molecule-1 (ICAM-1) in MOVAS-1 mouse smooth muscle cells (VSMCs) transfected with an ICAM-1 luciferase reporter when used at a concentration of 20 μM.
Usesinhibits AIDS virus infection in vitro and tumor necrosis factor-alpha (TNF), interleukin (IL)-1beta, and causes a marked depression of chemiluminescence activity
UsesMaltotetraose is a maltooligosaccharide that is used for research and diagnostic purposes. They can also be used in nutrients and healthcare.
DefinitionChEBI: A maltotetraose tetrasaccharide in which the glucose residue at the reducing end is in the aldehydo open-chain form.
34612-38-9DTXSID50865722CHEBI:28460